What's new? Log in Free sign up

Tottenham Acquisition I (TOTA)

Company Profile

Company profile

Ticker

TOTA, TOTAU, TOTAW, TOTAR

Exchange

CEO

Jason Ma

Incorporated

British Virgin Islands

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Entergy Arkansas • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

TOTA stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Exchange delisting (amended)

Entry into a Material Definitive Agreement

Additional proxy soliciting materials

Notice of effectiveness

Proxy related to merger

Letter from SEC

Preliminary revised proxy

16 Dec 20

Additional proxy soliciting materials

Clene Nanomedicine Presents Blinded Interim Results from

Preliminary revised proxy

Latest ownership filings

View all

BASSO CAPITAL MANAGEMENT, L.P.

BASSO CAPITAL MANAGEMENT, L.P.

Karpus Management, Inc.

Polar Asset Management Partners Inc.

Change in insider ownership

Change in insider ownership

Change in insider ownership

Change in insider ownership

Change in insider ownership

Change in insider ownership

Financial summary

Financial statements Chart TOTA financial data

Quarter (USD)	Sep 20	Jun 20	Mar 20	Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q1 2024

TOTA institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	3	3	–
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	260.41 mm	260.41 mm	–
Total shares	22.84 mm	22.84 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
General Resonance	15.98 mm	$260.41 mm	0.0%
4life Research	4.00 mm	$0.00	0.0%
UTHR United Therapeutics	2.87 mm	$0.00	0.0%

Largest transactions	Shares	Bought/sold	Change
UTHR United Therapeutics	2.87 mm	0.00	0.0%
General Resonance	15.98 mm	0.00	0.0%
4life Research	4.00 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.